Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 10 IN WATER IN PLASTIC CONTAINER versus OSMITROL 15 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 10 IN WATER IN PLASTIC CONTAINER versus OSMITROL 15 IN WATER.
OSMITROL 10% IN WATER IN PLASTIC CONTAINER vs OSMITROL 15% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Increases plasma osmolality, drawing water from tissues into the bloodstream, thereby reducing intracranial pressure and cerebral edema.
Osmotic diuretic; increases plasma osmolality, drawing water from extravascular to intravascular space, thereby reducing intracranial and intraocular pressure.
Initial: 0.25–1 g/kg (25–100 mL of 10% solution) IV over 30–60 minutes. May repeat every 6–12 hours if needed. Typical adult dose: 50–100 g IV. Maximum: 2 g/kg per dose.
IV infusion of 50-200 g over 30-60 minutes as a 15% solution; typical adult dose is 1.5-2 g/kg every 6-8 hours.
None Documented
None Documented
Terminal half-life approximately 1.5 hours in normal renal function; prolonged in renal impairment (up to 36 hours in anuria).
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function; prolonged to 24–36 hours in anuria or severe renal impairment.
Primarily renal; >90% excreted unchanged in urine via glomerular filtration; <5% biliary/fecal.
Primarily renal excretion as unchanged drug; >97% eliminated by glomerular filtration within 24 hours. Minimal biliary/fecal elimination (<3%).
Category C
Category C
Osmotic Diuretic
Osmotic Diuretic